Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
contents of platelet dense granules?
|
ADP, calcium
|
|
contents of platelet alpha granules?
|
vWF, fibrinogen
|
|
Contents of basophils?
|
Dense granules
1. heparin 2. histamine 3. vasoactive amines 4. leukotrienes Unlike mast cells, basophils are found in the blood. |
|
Ways that eosinophils decrease mast cell effects?
|
histaminase
arylsulfatase |
|
Causes of eosinophilia
|
NAACP
Neoplastic Asthma Allergic processes Collagen vascular diseases Parasites (invasive) |
|
hypersegmented polys
|
B12 and folate deficiency
|
|
anti-AB antibodies are of what isotype?
|
IgM- don't cross the placenta
anti Rh are IgG- can cross the placenta |
|
Activators and inactivators of bradykinin?
|
Kallikrein*- activator
ACE- inactivator Kallikrein- also activates plasminogen --> plasmin |
|
Activity of plasmin in the complement pathway?
|
C3 --> C3a
|
|
Hemophilia B
|
deficiency of factor IX
|
|
Aggregates platelets
|
GpIIb/IIIa + fibrinogen
Glanzmann's thrombastheneia- deficiency in GpIIb/IIIa |
|
Adheres platelets to subendothelial collagen
|
GpIb (platelet) and vWF
Bernard-Soulier- deficient in GpI Von Willebrand disease- deficient in vWF |
|
Irreversibly blocked by clopidogrel and ticlopidine
|
ADP receptor
- blocks expression of GpIIb/IIIa |
|
Signals for platelet aggregation
|
1. TxA2 released by platelets
2. PGI2 and NO release by endothelial cells |
|
Abciximab
|
inhibits GpIIb/IIIa
|
|
warfarin inhibits...
|
epoxide reductase - no activated vit K
|
|
Action of protein C (APC)
|
cleaves and inactivates Va, VIIIa
*Factor V Leiden mutation - V resistant to APC --> procoag |
|
tpa action
|
Activates plasminogen to plasmin
|
|
Acanthocyte (spur cell)
|
Liver disease
abetalipoproteinemia - Looks like a star |
|
Basophilic stippling
|
Thalassemias
Anemia of chronic disease Iron deficiency Lead poisoning |
|
Bite cell
|
G6PD deficiency
|
|
Teardrop cell
|
Bone marrow infiltration (myelofibrosis)
|
|
Target cell
|
HbC disease- mild sickle cell
Asplenia Liver disease Thalassemia |
|
Heinz body
|
denature hemoglobin- from oxidated iron (ferrous to ferric)
- leads to bite cells Alpha thalassemia, G6PD deficiency |
|
Howell-Jolly bodies
|
basophilic nuclear remnants in rbcs
- hypo or asplenia |
|
Hb Barts
|
alpha thal
- deletion of 4 genes- not compatible with life - tetrameric gamma |
|
HbH disease
|
alpha thal
- deletion of 3 genes - tetrameric beta |
|
diagnosis of beta-thal minor
|
Increased HbA2, HbF (alpha2, gamma 2)
- heterozygote |
|
beta thal major
|
absent beta chain
- requires blood transfusion - marrow expansion --> crew cut on skull xray (skeletal deformities) - target cells |
|
Lb poisoning effect on RBCs?
|
Inhibits ferrochelatase and d-ALA dehydratase --> decrease heme synthesis
- protoporphyrin elevated in blood Inhibits RNA degradation --> basophilic stippling |
|
Causes of sideroblastic anemia
|
- defect in heme synthesis
- hereditary (d-ALA synthase) - EtOH - Lb - Increased Fe, normal TIBC, increased ferritin |
|
Nonmegaloblastic macrocytic anemias
|
1. liver disease
2. EtOHism w/o B12 or folate def- bone marrow suppression 3. Reticulocytosis- increase MCV 4. Metabolic- purine and pyrimidine synthesis disorders 5. Drugs: 5-Fu, AZT, hydroxyurea |
|
Intravascular hemolysis, normocytic, normochromic anemia
|
1. PNH
2. Autoimmune - cold agglutinins (IgM) 3. Mechanical destruction (aortic stenosis, prosthetic valve) |
|
Anemia of chronic disease
|
inflammation --> increased hepcidin --> decreased release of iron from macrophages --> decreased iron, TIBC and increased ferritin
* normocytic --> microcytic |
|
viral agents that cause aplastic anemia
|
1. Parbovirus B19
2. EBV 3. HIV |
|
Drugs that can cause aplastic anemia?
|
1. benzene
2. chloramphenicol 3. alkylating agents 4. antimetabolites |
|
hemolytic anemia in a newborn
|
pyruvate kinase deficiency
- decreased ATP --> rigid RBCs - membrane damage --> extravascular hemolysis |
|
pink urine- heme synthesis disease
|
Acute intermittent porphyria
- porphobilinogen deaminase defective --> accumulated porphobilinogen, d-ALA and uroporphyrin 5Ps Painful abdomen Pink urine Polyneuropathy Pscyhological disturbances Precipitated by durgs tx: Glu, heme--> inhibit ALA synthase |
|
blistering cutaneous photosensitivity- heme synthesis disease
|
Porphyria Cutanea Tarda
- Urophyrinogen decarboxylase defect - Uroporphyrin accumulates --> tea colored urine *most common porphyria |
|
Dimercaprol and EDTA
|
1st line for Lb poisoning in adults
- succimer in kids |
|
Increased bleeding time but normal platelet count
|
Glanzmann's thrombasthenia
- decreased platelet to platelet aggregation |
|
ITP
|
- antibodies against GpIIb/IIIa --> platelet destruction
decrease platelet count, increased bleeding time |
|
Neuro, renal, fever, thrombocytopenia, microangiopathic hemolytic anemia
|
TTP
- ADAMTS 13 deficiency--> large vWF multimers --> aggregation and thrombosis labs: shistocytes and increased LDH |
|
hemophilia lab abnormality
|
Increased PTT
|
|
Haptoglobin in hemolytic anemia?
|
Decreased because binds hemoglobin and carries it out in urine etc
|
|
CD markers on Reed-Sternberg cells
|
CD30
CD15 Hodgkin's lymphoma |
|
Hodgkin's lymphoma more common in women
|
Nodular sclerosing
- young adults - collagen banding - lacunar cells - excellent prognosis |
|
Hodgkin's lymphoma- roughly equal lymp/RS ratio
|
Mixed cellularity
- LOTs of RS cells - Intermediate prognosis |
|
"Hodgkin's lymphoma" with different pathophys than others
|
Nodular Lymphoctye predominant Hodgkin's Lymhoma (NLPHL)
- RS cells (popcorn cells) express CD20 (CD15, CD30 negative) --> can progress to diffuse large B cell lymphoma - high lymph/RS - Excellent prognosis - males less than 35 |
|
Hodgkin's with worst prognosis
|
Lymphocyte depleted
- rare - RS - older males with disseminated disease |
|
Starry sky appearance
|
Burkitt's
t(8,14)- c-myc next to Ig gene - sheets of lymphs with macrophages interspersed - EBV - |
|
t (11,14)
|
Mantle cell lymphoma
- older males - poor prognosis - CD5 + |
|
t (14, 18)
|
Follicular lymphoma
- bcl-2 expression --> inhibits apoptosis - Can develop into diffuse B cell lymphoma - difficult to cure |
|
HTLV-1 causes this
|
Adult T cell lymphoma
- cutaneous lesions - Japan, West Africa, Caribbean - Aggressive |
|
Mycosis fungoides/ Sezary syndrome
|
cutaneous patches and nodules
- INDOLENT |
|
What do the two T cell NHLs have in common
|
T-cell lymphoma and Mycosis fungoides
1. Cutaneous lesions 2. Adults |
|
t (12, 21)
|
ALL
- better prognosis |
|
Presents with bone marrow involvement in childhood
|
ALL
|
|
Presents as a mediastinal mass in adolescent males
|
ALL
|
|
Markers for ALL
|
TdT+ (pre T and B cells)
CALLA+ |
|
t (9,22)
|
CML or poor prognosis in ALL
- bcr-abl |
|
Smudge cells in peripheral blood smear with warm antibody autoimmune hemolytic anemia
|
SLL
CLL- more peripheral blood lymphocytosis - Older adults |
|
TRAP stain
|
Hairy Cell leukemia
- elderly - mature B cells- filamentous hairlike projections |
|
t (15,17)
|
APML
|
|
Auer rods
|
azurophilic granules- APML, AML
|
|
Responds to all-trans retinoic acid
|
APML (M3)
- induces differentiation of myeloblasts - add arsenic salts - tx can induce the release of auer rods --> DIC |
|
Can progress to AML or ALL
|
CML
|
|
imatinib
|
anti-bcr-abl
- tx for CML |
|
low leuk alk phos
|
CML
|
|
leukemoid reaction
|
Increase WBC with left shift, increased leuk alkaline phosphatase
|
|
t (11,22)
|
Ewing's sarcoma
|
|
histiocytosis X
|
proliferative disorder of Langerhans cells
- Birbeck granules on EM - S-100 and CD1a markers |
|
S-100 and CD1a markers
|
defective Langerhan's cells in Histiocytosis X
|
|
JAK3 mutations
|
PCV, Essential thromboyctosis, myelofibrosis
NOT in CML |
|
Used to anticoagulate patients with heparin induced thrombocytopenia
|
Lepirudin, bivalirudin
- directly inhibits thrombin |
|
Tx for tpa or streptokinase toxicity?
|
aminocaproic acid
|
|
MTX toxicity?
|
myelosuppression- use leukovorin (folinic acid rescue)
*Leukovorin does not work with 5FU because cannot make dTMP from dUMP - rescue 5-FU with thymidine |
|
6-MP variant that CAN be given with allopurinol?
|
6-thioguanine (6-TG)
- purine analog --> decreases de novo purine synthesis |
|
Cytarabine (ara-C)
|
Pyrimidine antagonist --> inhibition of DNA polymerase
|
|
Antimetabolites that inhibit pyrimidine synthesis
|
5-FU, cytarabine
|
|
Antimetabolites that inhibit purine synthesis
|
6-MP, 6-TG
|
|
Antitumor antibiotic used to treat childhood tumors
|
Dactinomycin (Actinomycin D)
- intercalates DNA "Kids ACT up" |
|
"A" in ABVD for Hodgkin's
|
Doxorubicin (Adriamycin), daunorubicin
- Intercalates DNA --> breaks DNA --> generates free radicals toxicity: cardiotoxicity, myelosuppression, alopecia |
|
"B" in ABVD for Hodgkin's
|
Bleomycin
- Induces formation of free radicals (G2 phase specific) toxicity: pulmonary fibrosis |
|
Alkylating agent that can result in hemorrhagic cystitis
|
cyclophosphamide, ifosfamide
- treat with mesna * requires bioactivation by liver |
|
Nitrosureas
|
Alkylating agents
- carmustine, lomustine, semustine, streptozocin - requires bioactivation - Crosses BBB - Use in brain tumors |
|
Busulfan
|
Alkylates DNA
- CML - ablate bone marrow pre transplant Toxicity: Pulmonary fibrosis, hyperpigmentation |
|
"O" in MOPP for Hodgkin's
|
Oncovin (vincristine)
- blocks formation of microtubule spindle toxicity: paralytic ileus, neuro toxicity (areflexia, peripheral neuritis) *Vinblastine is similar- bone marrow suppression |
|
Carboplatin
|
- like cisplatin
- cross links DNA |
|
Hydroxyurea mechanism
|
Inhibits Ribonucleotide Reductase
- Melanoma, CML, sickle cell |